April 13, 2021 (LifeSiteNews) — The US Food & Drug Administration (FDA) is reversing a Trump-era decision banning the dispensation of abortion-inducing drugs by mail, claiming the policy is justified due to COVID-19 restrictions in various states supposedly making in-person consultations more difficult or dangerous.
Politico reports that on Monday, acting FDA Commissioner Janet Woodcock declared it safe to allow mifepristone, the first half of the chemical abortion cocktail RU-486, to be taken home without medical supervision, noting that it would reduce risks of contracting the coronavirus.
Under the Trump administration, the FDA had warned abortion-by-mail distributors that their flouting of the Risk Evaluation and Mitigation Strategy (REMS) program requirements, which ensure that providers can “assess the duration of the pregnancy accurately, diagnose ectopic pregnancies, and provide surgical intervention in cases of incomplete abortion or severe bleeding, or to have made arrangements for others to provide such care” — and give women “access to medical facilities for emergency care” — could expose themselves to regulatory action potentially “including seizure or injunction, without further notice.”
The abortion lobby sued the administration over the rule, and in January the US Supreme Court allowed the administration to enforce it, thought that ruling is mute with
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors